Brightsurf Science News & Current Events

July 06, 2002
Transmission of drug-resistant HIV on the rise
A rising number of San Franciscans are being infected with HIV that is already resistant to some classes of antiretroviral drugs, report researchers from the Gladstone Institute of Virology and Immunology in the July 10th issue of the Journal of the American Medical Association.

Exposure to hepatitis C has no effect on antiretroviral treatment outcomes in HIV patients
A study of HIV-infected patients in Baltimore, Maryland, revealed that individuals seropositive for hepatitis C had similar clinical outcome measures when treated with antiretroviral drug regimens compared to seronegative patients.

New UNC study reveals screening tests can boost early discovery of AIDS virus
Early, widespread diagnosis of acute infection with HIV, the virus that causes AIDS, is not only possible but also feasible -- by pooling blood samples from people being screened for HIV and conducting nucleic acid tests on those grouped specimens, a new study shows.

Hepatitis C infection does not alter HIV progression or treatment
Resolving conflicting reports about the effect of hepatitis C virus infection on the progression of HIV disease, a Hopkins study of nearly 2,000 HIV patients shows that hepatitis C does not increase risk of death, accelerate the development of AIDS, or curb the value of antiretroviral HIV therapy.

Northwestern researcher calls for simplified, less toxic HIV therapies
HIV researchers and clinicians should develop more simplified and less toxic strategies to insure patient compliance and quality of life without sacrificing the potency of a protease inhibitor-containing regimen, contends Northwestern University infectious disease expert Robert L.

Drug combinations reduce HIV levels in untreated patients
Combinations of drugs can significantly reduce the concentration of HIV in patients' bodies, even in those with advanced HIV disease, according to interim results of a study presented today (July 9, 2002) at the XIV International AIDS Conference in Barcelona, Spain. is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to